News Agency
Men's Weekly

Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program

  • Written by PR Newswire
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout

SINGAPORE and PRINCETON, N.J., Oct. 27, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech developing a novel treatment for gout, today announced the successful completion of an End-of-Phase 2 meeting with US FDA for its...

Read more: Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program

Defence Recruitment: Building Australia’s Future Security Workforce

Australia’s defence sector is one of the nation’s most vital and rapidly evolving industries, offering stable and rewarding careers for individuals committed to protecting national interests. With the growing need for advanced technologies, cybersecurity, and global defence partnerships, opportunities in defence... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion